Literature DB >> 20218848

Advances in pneumococcal vaccines: the 13-valent pneumococcal conjugate vaccine received market authorization in Europe.

Ralf R Reinert, Peter Paradiso, Bernard Fritzell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20218848     DOI： 10.1586/erv.10.6

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN： 1476-0584            Impact factor:   5.217


× No keyword cloud information.
  14 in total

1.  Capsule Prolongs Survival of Streptococcus pneumoniae during Starvation.

Authors:  Shigeto Hamaguchi; M Ammar Zafar; Michael Cammer; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

2.  Immunization with a ZmpB-based protein vaccine could protect against pneumococcal diseases in mice.

Authors:  Yi Gong; Wenchun Xu; Yali Cui; Xuemei Zhang; Run Yao; Dairong Li; Hong Wang; Yujuan He; Ju Cao; Yibing Yin
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

3.  The stubborn persistence of adult pneumococcal pneumonia as a public health problem.

Authors:  Rosalind Hollingsworth; Raul Isturiz
Journal:  Hum Vaccin Immunother       Date:  2014-02-19       Impact factor: 3.452

4.  How I treat late effects in adults after allogeneic stem cell transplantation.

Authors:  Bipin N Savani; Michelle L Griffith; Shubhada Jagasia; Stephanie J Lee
Journal:  Blood       Date:  2010-12-30       Impact factor: 22.113

5.  The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A.

Authors:  David Cooper; Xinhong Yu; Mohinder Sidhu; Moon H Nahm; Philip Fernsten; Kathrin U Jansen
Journal:  Vaccine       Date:  2011-07-18       Impact factor: 3.641

Review 6.  An evaluation of emerging vaccines for childhood pneumococcal pneumonia.

Authors:  Julia Webster; Evropi Theodoratou; Harish Nair; Ang Choon Seong; Lina Zgaga; Tanvir Huda; Hope L Johnson; Shabir Madhi; Craig Rubens; Jian Shayne F Zhang; Shams El Arifeen; Ryoko Krause; Troy A Jacobs; Abdullah W Brooks; Harry Campbell; Igor Rudan
Journal:  BMC Public Health       Date:  2011-04-13       Impact factor: 3.295

7.  Pneumococcal conjugate vaccine for adults: a new paradigm.

Authors:  Peter R Paradiso
Journal:  Clin Infect Dis       Date:  2012-04-11       Impact factor: 9.079

Review 8.  Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?

Authors:  A Torres; P Bonanni; W Hryniewicz; M Moutschen; R R Reinert; T Welte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-23       Impact factor: 3.267

Review 9.  Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.

Authors:  Catherine Weil-Olivier; Mark van der Linden; Iris de Schutter; Ron Dagan; Lorenzo Mantovani
Journal:  BMC Infect Dis       Date:  2012-09-07       Impact factor: 3.090

10.  Novel polysaccharide-protein conjugates provide an immunogenic 13-valent pneumococcal conjugate vaccine for S. pneumoniae.

Authors:  Allison E B Turner; Jonas E Gerson; Helen Y So; Daniel J Krasznai; Adrienne J St Hilaire; Donald F Gerson
Journal:  Synth Syst Biotechnol       Date:  2017-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.